Skip to main content
Article
Clinical significance of circulating DNA microsatellite markers in plasma of melanoma patients.
Annals of the New York Academy of Sciences (2006)
  • Takahiro Nakayama, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA
  • Bret Taback, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA
  • Duc‐Hanh Nguyen, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA
  • Dorcas D. Chi, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA
  • Donald L. Morton, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA
  • Yoshiyuki Fujiwara, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, California 90404, USA
  • Dave S. B. Hoon
Publication Date
January 25, 2006
DOI
10.1111/j.1749-6632.2000.tb06596.x
Citation Information
Takahiro Nakayama, Bret Taback, Duc‐Hanh Nguyen, Dorcas D. Chi, et al.. "Clinical significance of circulating DNA microsatellite markers in plasma of melanoma patients." Annals of the New York Academy of Sciences Vol. 906 Iss. 1 (2006) p. 87 - 98
Available at: http://works.bepress.com/dave-hoon/247/